论文部分内容阅读
目的 :研究促肝细胞生长素治疗重肝炎的临床疗效。方法 :选择70例重肝倾向肝炎病人 ,随机分为治疗组及对照组 ,每组各35例 ,对照组应用保肝退黄支持治疗 ,治疗组在对照组基础上每日加用促肝细胞生长素。结果 :治疗组有效率77 14 % ,对照组有效率54 2 % ,两组比较有显著性差异 (P<0 05)。重症肝炎的发生率 :对照组28 5 % ,治疗组为14 29 % ,两者比较有高显著性差异 (P<0 01)。结论 :促进细胞生长素对重肝倾向型肝炎的治疗有效 ,并可降低重症肝炎的发生率。
Objective: To investigate the clinical efficacy of hepatocyte growth-promoting hormone in the treatment of severe hepatitis. Methods: Seventy patients with severe hepatitis with hepatitis were randomly divided into treatment group and control group, with 35 cases in each group. The control group was treated with Baogan decoction supportive therapy. The treatment group was added daily with hepatocyte-promoting cells Auxin Results: The effective rate was 77.14% in the treatment group and 54.2% in the control group, with significant difference between the two groups (P <0.05). The incidence of severe hepatitis was 28.5% in the control group and 14.29% in the treatment group, with significant differences between the two groups (P <0.01). Conclusion: The promotion of cytokinin is effective in the treatment of severe hepatitis with hepatitis and can reduce the incidence of severe hepatitis.